CanSino Biologics Inc
688185
Company Profile
Business description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Contact
185 South Avenue
401-420, 4th Floor, Biomedical Park
TEDA West District
Tianjin
CHNT: +86 4009222099
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,105
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,826.40 | 15.50 | -0.18% |
CAC 40 | 7,723.47 | 27.20 | 0.35% |
DAX 40 | 24,073.67 | 286.22 | 1.20% |
Dow JONES (US) | 44,406.36 | 422.17 | -0.94% |
FTSE 100 | 8,806.53 | 16.38 | -0.19% |
HKSE | 23,887.83 | 28.23 | -0.12% |
NASDAQ | 20,412.52 | 188.59 | -0.92% |
Nikkei 225 | 39,587.68 | 223.20 | -0.56% |
NZX 50 Index | 12,764.95 | 1.65 | -0.01% |
S&P 500 | 6,229.98 | 49.37 | -0.79% |
S&P/ASX 200 | 8,589.30 | 13.70 | -0.16% |
SSE Composite Index | 3,473.13 | 0.81 | 0.02% |